Position
Bridgewater in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$3.39M$772.64 → $623.54
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 72.7K | $56.1M | — | — | — | 0.2% |
| Q1 2026 | 22.7K | $17.6M | $772.64 | $17.5K | −$38.6M | 0.1% |
| Q2 2026 | 51.3K | $32M | $623.54 | −$3.39M | $17.8M | 0.1% |